Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Yao JC, Guthrie KA, Moran C. et al.
Phase III prospective randomized comparison trial of depot octreotide plus interferon Alfa-2b versus depot octreotide plus bevacizumab in patients with advanced carcinoid tumors: SWOG S0518.

J Clin Oncol 2017;
35 (15) 1695-1703

Bibliographische Angaben herunterladen

Aufrufen in: